— McKesson Corporation (NYSE: MCK) reported its third-quarter 2020 adjusted earnings of $3.81 per share versus $3.56 per share expected.
— Total revenue rose by 5% to $59.17 billion versus $59.36 billion expected.
— On an FX-adjusted basis, revenues grew by 6%, primarily driven by growth in the US Pharmaceutical and Specialty Solutions segment, largely due to branded pharmaceutical price increases and higher volumes from retail national account customers.
— Revenues from the US Pharma segment increased by 6% driven by branded pharmaceutical price increases and increased volumes from retail national account customers.
— European Pharmaceutical Solutions segment revenue remained flat on a reported basis and up 3% on an FX-adjusted basis, driven primarily by growth in the pharmaceutical distribution business.
— Revenue from the Medical-Surgical Solutions segment increased by 6% driven by higher pharmaceutical volumes and an early start to the influenza season.
— The company reaffirmed fiscal 2020 adjusted EPS guidance range of $14.60–14.80. The consensus estimates EPS of $14.70 for the full year.
Philip Morris International Inc. (NYSE: PM) reported Third-quarter 2021 earnings results today. Net revenues increased 9% year-over-year to $8.1 billion. The reported net income amounted to $2.42 billion compared to
Halliburton (NYSE: HAL) reported third-quarter 2021 financial results before the regular market hours on Tuesday. The company reported Q3 revenue of $3.9 billion, up 30% year-over-year and lower than the
Johnson & Johnson (NYSE: JNJ) reported third-quarter 2021 financial results before the regular market hours on Tuesday. The pharmaceutical giant reported revenue of $23.3 billion, up 10.7% year-over-year, with operational